Your browser doesn't support javascript.
loading
Adrenal suppression from glucocorticoids: preventing an iatrogenic cause of morbidity and mortality in children.
Ahmet, Alexandra; Mokashi, Arati; Goldbloom, Ellen B; Huot, Celine; Jurencak, Roman; Krishnamoorthy, Preetha; Rowan-Legg, Anne; Kim, Harold; Pancer, Larry; Kovesi, Tom.
Afiliação
  • Ahmet A; Pediatrics, Division of Endocrinology, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.
  • Mokashi A; Pediatrics, University of Ottawa, Ottawa, Ontario, Canada.
  • Goldbloom EB; Pediatrics, Division of Endocrinology, IWK Health Centre, Halifax, Nova Scotia, Canada.
  • Huot C; Pediatrics, Division of Endocrinology, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.
  • Jurencak R; Pediatrics, University of Ottawa, Ottawa, Ontario, Canada.
  • Krishnamoorthy P; Pediatrics, Division of Endocrinology, University of Montreal, Montreal, Quebec, Canada.
  • Rowan-Legg A; Pediatrics, CHU Sainte-Justine, Montreal, Quebec, Canada.
  • Kim H; Pediatrics, University of Ottawa, Ottawa, Ontario, Canada.
  • Pancer L; Pediatrics, Division of Rheumatology, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.
  • Kovesi T; Pediatrics, Division of Endocrinology, Montreal Childrens Hospital, Montreal, Quebec, Canada.
BMJ Paediatr Open ; 3(1): e000569, 2019.
Article em En | MEDLINE | ID: mdl-31750407
ABSTRACT
Adrenal suppression (AS) is an important side effect of glucocorticoids (GCs) including inhaled corticosteroids (ICS). AS can often be asymptomatic or associated with non-specific symptoms until a physiological stress such as an illness precipitates an adrenal crisis. Morbidity and death associated with adrenal crisis is preventable but continues to be reported in children. There is a lack of consensus about the management of children at risk of AS. However, healthcare professionals need to develop an awareness and approach to keep these children safe. In this article, current knowledge of the risk factors, diagnosis and management of AS are reviewed while drawing attention to knowledge gaps and areas of controversy. Possible strategies to reduce the morbidity associated with this iatrogenic condition are provided for healthcare professionals.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: BMJ Paediatr Open Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: BMJ Paediatr Open Ano de publicação: 2019 Tipo de documento: Article